Recombinant activated factor VII as a temporary reversal agent for warfarin anticoagulation: a cautionary report on an off-label application.
Kalainov
David M
DM
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Valentino
Leonard A
LA
D000925:Anticoagulants / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D008875:Middle Aged; D011300:Preoperative Care / Q000379:methods*; D011994:Recombinant Proteins; D017006:Rotator Cuff / Q000601:surgery; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects* / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D011994:Recombinant Proteins; D014859:Warfarin; D015942:Factor VIIa